600201 生物股份
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.2865.4344.0737.4568.437
总资产报酬率 ROA (%)1.7814.2773.2435.9356.847
投入资产回报率 ROIC (%)2.1755.3083.9897.3218.315

边际利润分析
销售毛利率 (%)57.92359.18955.17261.88061.597
营业利润率 (%)24.03619.72216.68823.34430.201
息税前利润/营业总收入 (%)20.05316.24813.05420.98928.867
净利润/营业总收入 (%)20.20617.33813.09121.90026.701

收益指标分析
经营活动净收益/利润总额(%)95.364107.875126.885108.23292.348
价值变动净收益/利润总额(%)-3.444-2.463-3.9960.7726.821
营业外收支净额/利润总额(%)0.0150.197-3.874-0.335-0.323

偿债能力分析
流动比率 (X)3.1983.5884.0694.0064.690
速动比率 (X)2.7973.2053.5633.5454.174
资产负债率 (%)20.49117.71716.27215.80416.172
带息债务/全部投入资本 (%)-4.019-4.500-5.055-4.757-4.831
股东权益/带息债务 (%)-2,309.486-2,169.748-1,933.175-2,063.599-2,032.820
股东权益/负债合计 (%)379.416440.760487.852505.154490.639
利息保障倍数 (X)-5.030-4.625-4.336-9.217-23.331

营运能力分析
应收账款周转天数 (天)228.382182.538175.724135.251134.481
存货周转天数 (天)220.889180.956171.026177.657176.581